The utility of anti-Müllerian hormone in the diagnosis and prediction of loss of ovarian function following chemotherapy for early breast cancer. (2017)
Attributed to:
MRC Centre for Reproductive Health at the University of Edinburgh
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.ejca.2017.10.001
PubMed Identifier: 29117576
Publication URI: http://europepmc.org/abstract/MED/29117576
Type: Journal Article/Review
Volume: 87
Parent Publication: European journal of cancer (Oxford, England : 1990)
ISSN: 0959-8049